These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 26236953

  • 1. Molecular Dynamics Simulations and Structural Network Analysis of c-Abl and c-Src Kinase Core Proteins: Capturing Allosteric Mechanisms and Communication Pathways from Residue Centrality.
    Tse A, Verkhivker GM.
    J Chem Inf Model; 2015 Aug 24; 55(8):1645-62. PubMed ID: 26236953
    [Abstract] [Full Text] [Related]

  • 2. Atomistic Modeling of the ABL Kinase Regulation by Allosteric Modulators Using Structural Perturbation Analysis and Community-Based Network Reconstruction of Allosteric Communications.
    Astl L, Verkhivker GM.
    J Chem Theory Comput; 2019 May 14; 15(5):3362-3380. PubMed ID: 31017783
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Exploring Molecular Mechanisms of Paradoxical Activation in the BRAF Kinase Dimers: Atomistic Simulations of Conformational Dynamics and Modeling of Allosteric Communication Networks and Signaling Pathways.
    Tse A, Verkhivker GM.
    PLoS One; 2016 May 14; 11(11):e0166583. PubMed ID: 27861609
    [Abstract] [Full Text] [Related]

  • 6. Molecular Determinants Underlying Binding Specificities of the ABL Kinase Inhibitors: Combining Alanine Scanning of Binding Hot Spots with Network Analysis of Residue Interactions and Coevolution.
    Tse A, Verkhivker GM.
    PLoS One; 2015 May 14; 10(6):e0130203. PubMed ID: 26075886
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding.
    Chen S, Brier S, Smithgall TE, Engen JR.
    Protein Sci; 2007 Apr 14; 16(4):572-81. PubMed ID: 17327393
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tyrosine Kinase Activation and Conformational Flexibility: Lessons from Src-Family Tyrosine Kinases.
    Meng Y, Pond MP, Roux B.
    Acc Chem Res; 2017 May 16; 50(5):1193-1201. PubMed ID: 28426203
    [Abstract] [Full Text] [Related]

  • 15. Kinome signaling through regulated protein-protein interactions in normal and cancer cells.
    Pawson T, Kofler M.
    Curr Opin Cell Biol; 2009 Apr 16; 21(2):147-53. PubMed ID: 19299117
    [Abstract] [Full Text] [Related]

  • 16. Structure-based network analysis of activation mechanisms in the ErbB family of receptor tyrosine kinases: the regulatory spine residues are global mediators of structural stability and allosteric interactions.
    James KA, Verkhivker GM.
    PLoS One; 2014 Apr 16; 9(11):e113488. PubMed ID: 25427151
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB, Roumiantsev S, Van Etten RA.
    Oncogene; 2001 Nov 22; 20(53):7744-52. PubMed ID: 11753652
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.